Bio Solution Co.,Ltd. (KOSDAQ:086820)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019
Period Ending	Dec 31, 2020	Dec 31, 2019
Pharmaceuticals	7.74B	8.88B
Pharmaceuticals Growth	-12.81%	-
Total	7.74B	8.88B
Total Growth	-12.81%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019
Period Ending	Dec 31, 2020	Dec 31, 2019
South Korea	7.40B	8.48B
South Korea Growth	-12.77%	-
Overseas	345.24M	400.71M
Overseas Growth	-13.84%	-
Total	7.74B	8.88B
Total Growth	-12.81%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error